KORU Medical Systems EBITDA Margin 2010-2025 | KRMD
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for KORU Medical Systems (KRMD) over the last 10 years. The current EBITDA margin for KORU Medical Systems as of March 31, 2025 is .
| KORU Medical Systems EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-03-31 | $0.04B | $0.00B | -11.43% |
| 2024-12-31 | $0.03B | $-0.01B | -15.15% |
| 2024-09-30 | $0.03B | $-0.01B | -19.35% |
| 2024-06-30 | $0.03B | $-0.01B | -23.33% |
| 2024-03-31 | $0.03B | $-0.01B | -31.03% |
| 2023-12-31 | $0.03B | $-0.01B | -35.71% |
| 2023-09-30 | $0.03B | $-0.01B | -35.71% |
| 2023-06-30 | $0.03B | $-0.01B | -31.03% |
| 2023-03-31 | $0.03B | $-0.01B | -31.03% |
| 2022-12-31 | $0.03B | $-0.01B | -32.14% |
| 2022-09-30 | $0.03B | $-0.01B | -33.33% |
| 2022-06-30 | $0.03B | $-0.01B | -36.00% |
| 2022-03-31 | $0.02B | $-0.01B | -29.17% |
| 2021-12-31 | $0.02B | $-0.01B | -26.09% |
| 2021-09-30 | $0.02B | $-0.01B | -23.81% |
| 2021-06-30 | $0.02B | $0.00B | -19.05% |
| 2021-03-31 | $0.02B | $0.00B | -17.39% |
| 2020-12-31 | $0.02B | $0.00B | -4.17% |
| 2020-09-30 | $0.03B | 0 | 0.00% |
| 2020-06-30 | $0.03B | $0.00B | 3.70% |
| 2020-03-31 | $0.02B | $0.00B | 8.33% |
| 2019-12-31 | $0.02B | $0.00B | 4.35% |
| 2019-09-30 | $0.02B | $0.00B | 4.76% |
| 2019-06-30 | $0.02B | $0.00B | 5.26% |
| 2019-03-31 | $0.02B | $0.00B | 10.53% |
| 2018-12-31 | $0.02B | $0.00B | 16.67% |
| 2018-09-30 | $0.02B | $0.00B | 25.00% |
| 2018-06-30 | $0.02B | $0.00B | 20.00% |
| 2018-03-31 | $0.01B | $0.00B | 14.29% |
| 2017-12-31 | $0.01B | $0.00B | 7.14% |
| 2017-06-30 | $0.01B | 0 | 0.00% |
| 2017-03-31 | $0.01B | 0 | 0.00% |
| 2016-11-30 | $0.01B | $0.00B | -8.33% |
| 2016-09-30 | $0.01B | $0.00B | -16.67% |
| 2016-06-30 | $0.01B | $0.00B | -11.11% |
| 2016-05-31 | $0.01B | $0.00B | 11.11% |
| 2015-08-31 | $0.01B | $0.00B | 11.11% |
| 2015-05-31 | $0.01B | 0 | 0.00% |
| 2014-08-31 | $0.01B | $0.00B | 12.50% |
| 2014-05-31 | $0.01B | $0.00B | 14.29% |
| 2013-08-31 | $0.01B | 0 | 0.00% |
| 2013-05-31 | $0.01B | $0.00B | 16.67% |
| 2012-05-31 | $0.00B | 0 | 0.00% |
| 2011-12-31 | $0.01B | $0.00B | -20.00% |
| 2010-06-30 | $0.00B | 0 | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.142B | $0.034B |
| KORU Medical Systems Inc. is a medical technology company. It focused on development, manufacturing and commercialization of patient-centric large volume subcutaneous infusion solutions. KORU Medical Systems Inc., formerly known as REPRO MEDSYSTEM, is based in MAHWAH, N.J. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.427B | 59.33 |
| Hims & Hers Health (HIMS) | United States | $12.608B | 131.00 |
| Tempus AI (TEM) | United States | $10.745B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.683B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.012B | 62.68 |
| Hinge Health (HNGE) | United States | $3.034B | 0.00 |
| Privia Health (PRVA) | United States | $2.827B | 193.25 |
| Enovis (ENOV) | United States | $1.816B | 10.12 |
| Schrodinger (SDGR) | United States | $1.807B | 0.00 |
| Phreesia (PHR) | United States | $1.595B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.555B | 0.00 |
| Omnicell (OMCL) | United States | $1.452B | 25.62 |
| Azenta (AZTA) | United States | $1.316B | 61.17 |
| 10x Genomics (TXG) | United States | $1.160B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.652B | 0.00 |
| Claritev (CTEV) | United States | $0.650B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.613B | 0.00 |
| Talkspace (TALK) | United States | $0.550B | 164.50 |
| Veradigm (MDRX) | United States | $0.476B | 0.00 |
| Standard BioTools (LAB) | United States | $0.403B | 0.00 |
| Outset Medical (OM) | United States | $0.371B | 0.00 |
| TruBridge (TBRG) | United States | $0.358B | 794.00 |
| Health Catalyst (HCAT) | United States | $0.285B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.261B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.209B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.128B | 0.00 |
| Pulmonx (LUNG) | United States | $0.128B | 0.00 |
| American Well (AMWL) | United States | $0.109B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.098B | 0.00 |
| CareCloud (CCLD) | United States | $0.092B | 3.52 |
| 111 (YI) | China | $0.073B | 0.00 |
| HeartBeam (BEAT) | United States | $0.056B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.048B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.034B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.031B | 0.00 |
| Zhongchao (ZCMD) | China | $0.027B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.022B | 0.00 |
| Precipio (PRPO) | United States | $0.017B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |